mrd testing in leukemia, lymphoma and myeloma
Published 5 years ago • 219 plays • Length 3:50Download video MP4
Download video MP3
Similar videos
-
2:51
mrd testing in acute leukemias
-
1:20
mrd in myeloma
-
1:53
what clinicians need to know about mrd testing for acute leukemias
-
1:04
real-world findings of mrd by mfc in aml
-
1:30
the clinical application of mrd testing in aml
-
8:53
how is mrd testing done?
-
3:07
minimal residual disease (mrd)
-
10:52
what are some possible uses of mrd testing?
-
1:32
methods to evaluate mrd in aml
-
1:39
an insight into mrd monitoring and mrd-driven treatment in aml
-
12:59
acute leukemias: is mrd already a surrogate for survival?
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
1:26
the current role of mrd in aml and challenges with implementing this in clinical practice
-
1:22
methods to measure mrd & its role in predicting patient outcomes in aml
-
1:02
challenges with measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
2:36
mrd testing in aml: the next steps in 2019
-
4:21
mrd as a monitoring technique of allosct and car-t in aml/all
-
2:35
mrd focus: why measurable residual disease testing is the future
-
8:42
assessing mrd in multiple myeloma
-
1:11
are idh mutations good minimal residual disease (mrd) markers in acute myeloid leukemia (aml)?
-
1:55
pros and cons of mrd testing in cll
-
2:18
the utility of measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)